ATE76069T1 - 5-nitrobenzo(de>isochinolin-1,3-dione, ihre herstellung und verwendung. - Google Patents

5-nitrobenzo(de>isochinolin-1,3-dione, ihre herstellung und verwendung.

Info

Publication number
ATE76069T1
ATE76069T1 AT87115310T AT87115310T ATE76069T1 AT E76069 T1 ATE76069 T1 AT E76069T1 AT 87115310 T AT87115310 T AT 87115310T AT 87115310 T AT87115310 T AT 87115310T AT E76069 T1 ATE76069 T1 AT E76069T1
Authority
AT
Austria
Prior art keywords
isochinolin
nitrobenzo
dione
preparation
compounds
Prior art date
Application number
AT87115310T
Other languages
German (de)
English (en)
Inventor
Fernandez Miguel Dr Brana
Castellano Jose Maria Berlanga
Moset Marina Dr Moran
Erich Dr Schlick
Gerhard Dr Keilhauer
Original Assignee
Knoll Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Knoll Ag filed Critical Knoll Ag
Application granted granted Critical
Publication of ATE76069T1 publication Critical patent/ATE76069T1/de

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D221/00—Heterocyclic compounds containing six-membered rings having one nitrogen atom as the only ring hetero atom, not provided for by groups C07D211/00 - C07D219/00
    • C07D221/02—Heterocyclic compounds containing six-membered rings having one nitrogen atom as the only ring hetero atom, not provided for by groups C07D211/00 - C07D219/00 condensed with carbocyclic rings or ring systems
    • C07D221/04—Ortho- or peri-condensed ring systems
    • C07D221/06—Ring systems of three rings
    • C07D221/14—Aza-phenalenes, e.g. 1,8-naphthalimide
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents

Landscapes

  • Organic Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Other In-Based Heterocyclic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Pyridine Compounds (AREA)
AT87115310T 1986-10-21 1987-10-20 5-nitrobenzo(de>isochinolin-1,3-dione, ihre herstellung und verwendung. ATE76069T1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
DE19863635711 DE3635711A1 (de) 1986-10-21 1986-10-21 5-nitrobenzo(de)isochinolin-1,3-dione, ihre herstellung und verwendung
EP87115310A EP0268093B1 (de) 1986-10-21 1987-10-20 5-Nitrobenzo[de]isochinolin-1,3-dione, ihre Herstellung und Verwendung

Publications (1)

Publication Number Publication Date
ATE76069T1 true ATE76069T1 (de) 1992-05-15

Family

ID=6312114

Family Applications (1)

Application Number Title Priority Date Filing Date
AT87115310T ATE76069T1 (de) 1986-10-21 1987-10-20 5-nitrobenzo(de>isochinolin-1,3-dione, ihre herstellung und verwendung.

Country Status (9)

Country Link
US (1) US5552544A (enExample)
EP (1) EP0268093B1 (enExample)
JP (1) JPS63104963A (enExample)
AT (1) ATE76069T1 (enExample)
AU (1) AU592474B2 (enExample)
CA (1) CA1331382C (enExample)
DE (2) DE3635711A1 (enExample)
ES (1) ES2037055T3 (enExample)
ZA (1) ZA877859B (enExample)

Families Citing this family (31)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE3939372A1 (de) * 1989-11-29 1991-06-06 Knoll Ag Mitonafide-infusionsloesung
DE3942280A1 (de) * 1989-12-21 1991-06-27 Knoll Ag N-substituierte naphthalimide, ihre herstellung und verwendung
US5235045A (en) * 1992-03-19 1993-08-10 Microbiomed Corporation Non-azo naphthalimide dyes
US5766600A (en) * 1993-08-09 1998-06-16 Microbiomed Corporation Non-azo naphtalimide dyes and uses for same
NZ335291A (en) 1996-10-21 2001-02-23 Allelix Biopharma Neurotrophin antagonist compositions
DE19714161A1 (de) * 1997-04-05 1998-10-08 Emtec Magnetics Gmbh Magnetischer Aufzeichnungsträger
CA2352045A1 (en) * 1998-11-25 2000-06-08 Merck Patent Gesellschaft Mit Beschraenkter Haftung Substituted benzo[de]isoquinoline-1,3-diones
MY164077A (en) * 1999-05-13 2017-11-30 Pharma Mar Sa Compositions and uses of et743 for treating cancer
US6492380B1 (en) * 1999-05-17 2002-12-10 Queen's University At Kingston Method of inhibiting neurotrophin-receptor binding
US6468990B1 (en) * 1999-05-17 2002-10-22 Queen's University At Kingston Method of inhibiting binding of nerve growth factor to p75 NTR receptor
MXPA02011319A (es) * 2000-05-15 2003-06-06 Pharma Mar Sa Analogos antitumorales de ecteinascidina 743.
BR0115162A (pt) * 2000-11-06 2003-10-21 Pharma Mar Sa Tratamentos antitumorais eficazes
DE10101319A1 (de) * 2001-01-09 2002-07-18 Schering Ag Morphometrisches Gewebe- oder Zellpräparat
GB0202544D0 (en) * 2002-02-04 2002-03-20 Pharma Mar Sa The synthesis of naturally occuring ecteinascidins and related compounds
US6693198B2 (en) * 2002-04-22 2004-02-17 Xanthus Life Sciences, Inc. Amonafide salts
US20040082788A1 (en) * 2002-07-08 2004-04-29 Chemgenex Therapeutics, Inc. Naphthalimide synthesis including amonafide synthesis and pharmaceutical preparations thereof
GB0312407D0 (en) * 2003-05-29 2003-07-02 Pharma Mar Sau Treatment
GB0324201D0 (en) * 2003-10-15 2003-11-19 Pharma Mar Sau Improved antitumoral combinations
PT1689404E (pt) * 2003-11-13 2008-12-15 Pharma Mar Sau Combinação de et-743 com pró-fármacos de fluorouracil para o tratamento do cancro
US20080255132A1 (en) * 2003-11-14 2008-10-16 Eric Rowinsky Combination Therapy Comprising the Use of Et-743 and Paclitaxel for Treating Cancer
GB0326486D0 (en) * 2003-11-14 2003-12-17 Pharma Mar Sau Combination treatment
EP1742920A2 (en) * 2004-05-05 2007-01-17 Unibioscreen S.A. Naphthalimide derivatives for the treatment of cancer
JP2008505862A (ja) * 2004-07-09 2008-02-28 ファルマ、マール、ソシエダード、アノニマ 予後分子マーカー
JP2008514688A (ja) * 2004-09-29 2008-05-08 ファルマ・マル・エス・アー， ソシエダッド・ユニペルソナル 抗炎症剤としてのエクテイナシジン化合物
PL1827500T3 (pl) * 2004-10-26 2009-09-30 Pharma Mar Sa Pegylowana liposomalna doksorubicyna w kombinacji z ekteinascydyną 743
DK1658848T3 (da) * 2004-10-29 2007-11-26 Pharma Mar Sa Formuleringer omfattende ecteinascidin og et disaccharid
US7947839B2 (en) * 2004-12-01 2011-05-24 Genentech, Inc. Heterocyclic-substituted bis-1,8 naphthalimide compounds, antibody drug conjugates, and methods of use
CN101304973A (zh) 2005-09-15 2008-11-12 佩因赛普托药物公司 调节神经营养蛋白介导的活性的方法
GB0522082D0 (en) * 2005-10-31 2005-12-07 Pharma Mar Sa Formulations
AU2007247355A1 (en) * 2006-05-05 2007-11-15 Unibioscreen S.A. 5-urea substituted naphthalimide derivatives, methods of production and pharmaceutical compositions for treating cancer
AU2008313634A1 (en) * 2007-10-19 2009-04-23 Pharma Mar, S.A. Prognostic molecular markers for ET-743 treatment

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ES459497A1 (es) * 1977-06-04 1978-04-16 Made Labor Sa Un metodo para la preparacion industrial de naftalimidas y sus derivados.
DE2944867A1 (de) * 1979-11-07 1981-05-27 Hoechst Ag, 6000 Frankfurt Kationische verbindungen der naphthalimid-reihe, verfahren zu deren herstellung und deren verwendung
US4614820A (en) * 1983-04-01 1986-09-30 Warner-Lambert Co. 3,6-disubstituted-1,8-naphthalimides
DE3481120D1 (de) * 1983-04-01 1990-03-01 Warner Lambert Co 3,6-disubstituierte-1,8-naphthalimide, verfahren zu ihrer herstellung und ihre verwendung.
DE3614414A1 (de) * 1986-04-29 1987-11-05 Knoll Ag Neue benzo(de)isochinolin-1,3-dione, ihre herstellung und verwendung
US4782064A (en) * 1986-07-21 1988-11-01 American Cyanamid Co. 2-heteroaryl-alkyl-1H-benz[de]-isoquinoline-1,3(2H)-diones

Also Published As

Publication number Publication date
DE3635711A1 (de) 1988-04-28
AU7999087A (en) 1988-04-28
EP0268093B1 (de) 1992-05-13
EP0268093A1 (de) 1988-05-25
JPS63104963A (ja) 1988-05-10
AU592474B2 (en) 1990-01-11
CA1331382C (en) 1994-08-09
ES2037055T3 (es) 1993-06-16
US5552544A (en) 1996-09-03
ZA877859B (en) 1989-06-28
DE3779053D1 (enExample) 1992-06-17

Similar Documents

Publication Publication Date Title
ATE76069T1 (de) 5-nitrobenzo(de>isochinolin-1,3-dione, ihre herstellung und verwendung.
DE3768922D1 (de) Anthrapyridon-verbindungen, ihre herstellung und ihre verwendung.
FI873043L (fi) Stabiliserat tyg.
ES527776A0 (es) Procedimiento de preparacion de derivados de 1,4-dihidropiridinas.
NO167378C (no) Fremgangsmaate for fremstilling av joderte aromatiske forbindelser.
DE3885534D1 (de) Arylphosphorderivate, ihre Herstellung und Verwendung.
NO890269D0 (no) Fremgangsmaate for fremstilling av 1,4-disubstituerte-piperidinyl-forbindelser.
DE3777604D1 (de) Makrolid-verbindungen, ihre herstellung und ihre verwendung.
NO168654C (no) Fremgangsmaate for polymerisering av 1,3-butadien.
ES510730A0 (es) "procedimiento para la preparacion de (2,2')-disulfuros de ditiazolilo".
ATE89826T1 (de) Antibakterielle verbindungen, ihre herstellung und verwendung.
NO167807C (no) Analogifremgangsmaate til fremstilling av 3',4'-dinitrogensubstituerte epipodofyllotoksinglukosidderivater.
NO871766D0 (no) Fremgangsmaate for fremstilling av terapeutisk aktive benzo(de)isokinolin-1,3-dioner.
IT8767940A0 (it) Procedimento microbiologico per lapreparazione di 9 alfa -idrossi4-androstene-3,17 dione
DE3784768D1 (de) Verwendung von zusammensetzungen auf basis von crotoxin, zur herstellung von medikamenten zur behandlung von carcinomen.
NO860273L (no) Fremgangsmaate for fremstilling av 4,4-dialkyl-2-azetidinoner.
ES514102A0 (es) "procedimiento para la fabricacion de derivados de la tetrahidros -5,6,7,7a 4h-tieno (3,2-c)piridinona-2".
DE3773027D1 (de) 3,3'(2h,2'h)-spirobibenzofuran-verbindungen und diese umfassende antioxidantien.
NO880409D0 (no) Fremgangsmaate for fremstilling av 14,15-substituerte lanosteroler.
NO874617D0 (no) Fremgangsmaate til fremstilling av 2,6-diamino-3-halogenobenzylpyridiner.
NO870387D0 (no) Fremgangsmaate for spaltning av polyhalogenerte aromatiske forbindelser.
FI873050A0 (fi) Foerfarande foer framstaellning av 6-amino-1,2-dihydro-1-hydroxi-2-imino-4-piperidinopyrimidin.
NO872624D0 (no) Fremgangsmaate for fremstilling av 3,7-dihydro-3-n-propyl-1h-purin-2,6-dion.
ES516069A0 (es) "procedimiento para la preparacion de derivados de 1,2,3-tiadiazol-5-il-urea".
NO875465D0 (no) Fremgangsmaate for fremstilling av aminoalkanoyl-dibenzo(d,g)(1,3,6)dioxazociner.

Legal Events

Date Code Title Description
REN Ceased due to non-payment of the annual fee